Skip to main content

Table 2 10-year competing mortality rates after radical cystectomy stratified by the Lee mortality index compared with the predicted values (Cruz et al. [2013])

From: Lee mortality index as comorbidity measure in patients undergoing radical cystectomy

Points

Predicted 10-year overall mortality(Cruz et al.[2013])

95% CI(Cruz et al.[2013])

Proportion of events*

Observed 10-year competing mortality

95% CI

p**

0

2.8%

1.3-4.2%

0/8

0.0%

NA

0.0002

1

4.0%

2.6-5.4%

1/12

9.4%

0.0-30.7%

0.4923

2

6.0%

4.8-7.3%

2/54

1.9%

0.0-5.6%

0.0088

3

9.1%

7.6-11%

4/59

3.5%

0.0-8.3%

0.0144

4

14%

12-16%

14/118

9.5%

2.7-16.3%

0.2134

5

21%

19-23%

20/109

17.8%

9.2-26.4%

0.4775

6

30%

27-33%

21/103

25.0%

13.9-36.1%

0.3940

7

40%

36-43%

36/97

36.0%

23.9-48.0%

0.5321

8

52%

48-55%

22/57

32.3%

17.4-47.1%

0.0114

9

62%

58-66%

22/52

49.8%

24.1-75.6%

0.3588

10

71%

67-76%

13/35

40.8%

19.7-61.8%

0.0060

11

81%

76-85%

12/21

55.6%

21.8-73.5%

0.0578

12

85%

81-90%

2/8

25.0%

0.0-52.1%

<0.0001

13

89%

85-94%

2/2

100%

NA

<0.0001

14+

95%

93-98%

0/0

NA

NA

NA

  1. With an overall p value of 0.0120, the observed competing mortality rates rated were somewhat lower than predicted. CI: confidence interval, NA: not available, *deaths of competing causes (other than bladder cancer) per number of patients in this risk group, **p values are raw values.